New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
07:06 EDTCRMECardiome reports Q4 EPS (53c), consensus (22c)
Reports Q4 revenue $3.9M, consensus $3.17M; The net loss in Q4 was largely due to an increase in SG&A expenses incurred to support the commercialization of BRINAVESS and AGGRASTAT.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 14, 2015
08:56 EDTCRMECardiome Aggrastat sales likely to bounce back, says Canaccord
Subscribe for More Information
May 13, 2015
07:06 EDTCRMECardiome still sees FY15 Aggrastat sales $24M-$25M
Subscribe for More Information
07:05 EDTCRMECardiome reports Q1 EPS 823c), consensus (30c)
Subscribe for More Information
May 12, 2015
08:40 EDTCRMECardiome enters into commercialization agreement with AOP Orphan Pharma
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use